YEH1 (Systematic name: YLL012) encodes a steryl ester hydrolase involved in lipid particle homeostasis. Key features include:
Function: Catalyzes the hydrolysis of steryl esters to free sterols and fatty acids, critical for membrane remodeling under stress conditions .
Localization: Found in intracellular lipid particles, with both N- and C-termini exposed to the cytoplasm .
Regulation: Expression is upregulated under heme-deficient conditions, enabling sterol storage mobilization .
YEH1 antibodies are typically monoclonal or polyclonal reagents developed using recombinant YEH1 protein or peptide epitopes. Validation strategies include:
These methods align with best practices for antibody validation, as emphasized in large-scale studies .
YEH1 antibodies have been pivotal in elucidating:
Lipid Storage Dynamics: Yeh1 hydrolyzes steryl esters during heme deficiency, enabling sterol redistribution for membrane integrity .
Interactions with Lipid Droplets: GFP-tagged YEH1 localizes to lipid particles, confirmed via fluorescence microscopy .
Genetic Pathways: Collaborative roles with paralogs YEH2 and TGL1 in lipid homeostasis .
The following strains are critical for functional analyses (adapted from ):
| Strain | Genotype | Application |
|---|---|---|
| YRS2090 | MATα yeh1::HIS3MX6 tgl1::kanMX4 YEH1-GFP-TRP1 | Localization studies |
| YRS2184 | MATa GAL1-GFP-YEH1 hem1::LEU2 | Heme-deficient regulation assays |
| YRS2740 | MATa rox3::kanMX4 YEH1-GFP-HIS3MX6 hem1::LEU2 | Transcriptional regulation analysis |
Cross-Reactivity: Potential overlap with homologous proteins (e.g., YEH2) necessitates rigorous validation using KO controls .
Epitope Accessibility: Membrane-associated localization of Yeh1 requires permeabilization for antibody binding in fixed cells .
Advances in recombinant antibody engineering (e.g., Fc silencing, half-life extension) could enhance YEH1 antibody utility for in vivo tracking. Additionally, CRISPR-based tagging and mass spectrometry may refine spatial-temporal resolution of Yeh1 activity.
KEGG: sce:YLL012W
STRING: 4932.YLL012W
YEH1 (encoded by the YEH1 gene) is a steryl ester hydrolase primarily found in Saccharomyces cerevisiae (Baker's yeast). This protein is significant in research because it plays a role in lipid metabolism pathways, particularly in the hydrolysis of steryl esters. The study of YEH1 and its antibodies contributes to our understanding of fundamental cellular processes in eukaryotic organisms. When conducting research with YEH1 antibodies, it's important to note that these reagents are typically used to detect and quantify the YEH1 protein in yeast samples, with applications in western blotting, immunoprecipitation, and immunohistochemistry protocols. Researchers often use YEH1 antibodies to investigate lipid homeostasis mechanisms in yeast as a model organism .
YEH1 antibodies, like most research-grade antibodies, require specific storage conditions to maintain their reactivity and specificity. The optimal storage conditions typically include maintaining the antibody at -20°C for long-term storage, with aliquoting recommended to avoid repeated freeze-thaw cycles that can degrade antibody performance. For working solutions, storage at 4°C for up to one month is generally acceptable.
To preserve antibody function:
Aliquot upon receipt to minimize freeze-thaw cycles
Store concentrated stock solutions at -20°C
Add carriers like BSA (0.1-1%) to dilute solutions to prevent adsorption to storage tubes
Avoid exposure to light for fluorophore-conjugated antibodies
Document the freeze-thaw history of each aliquot
Researchers should validate the activity of stored antibodies periodically, especially when using them for quantitative applications in YEH1 protein research .
When conducting western blot experiments with YEH1 antibodies, proper controls are essential for reliable and interpretable results. The following controls should be incorporated:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirms antibody reactivity | Lysate from wild-type S. cerevisiae expressing YEH1 |
| Negative Control | Establishes specificity | Lysate from YEH1 knockout yeast strain |
| Loading Control | Normalizes protein quantities | Antibody against housekeeping protein (e.g., Act1) |
| Secondary Antibody Control | Detects non-specific binding | Primary antibody omitted, secondary antibody only |
| Blocking Peptide Control | Confirms epitope specificity | Pre-incubation of antibody with YEH1 peptide |
The inclusion of these controls helps distinguish true signals from artifacts and enables accurate quantification of YEH1 protein levels. When interpreting results, researchers should look for a single band at the expected molecular weight of YEH1 (~66 kDa) in positive controls, with absence of this band in negative controls .
Optimizing immunoprecipitation (IP) protocols for YEH1 detection requires careful consideration of yeast growth conditions, as YEH1 expression and post-translational modifications may vary significantly depending on cellular metabolic states. To achieve robust and reproducible results:
Growth condition optimization:
Compare YEH1 expression in fermentative vs. respiratory growth
Monitor expression changes during different growth phases
Assess the impact of carbon source variation on YEH1 levels
Lysis buffer considerations:
Use buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40
Include protease inhibitors to prevent degradation
Add phosphatase inhibitors if studying YEH1 phosphorylation states
Consider detergent selection based on YEH1's membrane association
IP protocol refinements:
Pre-clear lysates to reduce non-specific binding
Optimize antibody-to-lysate ratios (typically 2-5 μg antibody per 500 μg protein)
Extend incubation times (4-16 hours at 4°C) for low-abundance conditions
Use gentle washing conditions to preserve weak interactions
Validation steps:
Confirm specificity using YEH1 knockout strains
Perform reciprocal IPs with known interaction partners
Compare results across different antibody clones if available
For quantitative comparisons between conditions, researchers should normalize IP efficiency using spike-in controls and carefully document all procedural variables .
When direct detection of native YEH1 proves challenging due to antibody limitations, epitope tagging provides a valuable alternative approach. The effectiveness of different tagging strategies depends on several factors:
Tag selection considerations:
Small tags (HA, FLAG, Myc) minimize functional interference
GFP/fluorescent protein tags enable live-cell imaging but may affect function
Tandem tags (3xFLAG, 6xHis) enhance detection sensitivity
Split tags can help assess protein topology
Tag placement optimization:
C-terminal tagging is generally less disruptive for YEH1
Avoid disrupting known functional domains
Consider creating multiple constructs with different tag positions
Validate that tagged versions maintain wild-type localization patterns
Expression system selection:
Genomic integration under native promoter preserves physiological expression
Plasmid-based expression offers flexibility but may cause overexpression artifacts
Inducible promoters allow temporal control of expression
Functional validation requirements:
Complementation assays in YEH1 deletion strains
Growth phenotype analysis under lipid metabolism challenge conditions
Enzymatic activity assays to confirm hydrolase function
Differentiating between the closely related steryl ester hydrolases YEH1 and YEH2 in yeast can be challenging due to their structural and functional similarities. To achieve specific detection:
Antibody selection strategies:
Use antibodies raised against unique epitopes not conserved between YEH1 and YEH2
Perform extensive cross-reactivity testing against purified proteins
Consider using monoclonal antibodies targeted to divergent regions
Experimental verification approaches:
Include both YEH1 and YEH2 knockout controls
Perform parallel immunoblotting with both antibodies
Use differential molecular weight migration patterns (YEH1: ~66 kDa, YEH2: ~62 kDa)
Enhanced specificity techniques:
Employ epitope competition assays with specific peptides
Utilize immunodepletion to remove cross-reactive antibodies
Consider two-color Western blotting for simultaneous detection
Alternative strategies when antibody specificity is insufficient:
Implement isoform-specific epitope tagging
Utilize mass spectrometry for definitive identification
Consider CRISPR-based endogenous tagging to maintain native expression levels
When interpreting results, researchers should account for potential functional redundancy and compensatory regulation between YEH1 and YEH2, which may complicate phenotypic analyses in single knockout systems .
YEH1 antibodies can serve as powerful tools in high-throughput screening (HTS) platforms designed to identify compounds or genetic factors that modulate lipid metabolism pathways. Effective implementation requires:
Assay development considerations:
Adapt YEH1 antibody detection to microplate formats
Optimize signal-to-noise ratio for automated detection systems
Develop quantitative readouts (e.g., fluorescence intensity, FRET-based systems)
Implement parallel viability assays to exclude cytotoxic effects
Screening platform design:
Primary screen: Monitor changes in YEH1 protein levels or post-translational modifications
Secondary screen: Assess effects on steryl ester hydrolase activity
Tertiary screen: Evaluate cellular lipid composition changes
Technical adaptations for HTS compatibility:
Develop homogeneous assay formats to minimize washing steps
Implement automated image analysis for high-content screens
Optimize reagent concentrations for miniaturized reaction volumes
Establish robust statistical parameters for hit identification
Validation strategies for identified modulators:
Dose-response relationships in secondary assays
Orthogonal methods to confirm specificity for YEH1-dependent pathways
Structure-activity relationship analysis for chemical modulators
Genetic interaction studies for gene modifiers
For maximum relevance, researchers can extend findings from yeast-based screens to mammalian systems, exploring whether identified modulators affect related mammalian lipid metabolism pathways. This translation requires careful consideration of evolutionary conservation and metabolic pathway differences .
Detecting post-translational modifications (PTMs) of YEH1 requires highly sensitive and specific techniques, particularly when these modifications occur at substoichiometric levels. The most effective approaches include:
Phosphorylation analysis:
Phos-tag™ SDS-PAGE followed by Western blotting with YEH1 antibodies
Immunoprecipitation with YEH1 antibodies followed by phospho-specific antibody detection
Mass spectrometry analysis of enriched phosphopeptides
Lambda phosphatase treatment controls to confirm phosphorylation specificity
Ubiquitination detection:
Denaturing immunoprecipitation to disrupt non-covalent interactions
Tandem ubiquitin-binding entity (TUBE) enrichment prior to YEH1 antibody detection
Sequential immunoprecipitation approaches (ubiquitin IP followed by YEH1 detection)
Use of proteasome inhibitors to stabilize ubiquitinated species
Other PTM analysis techniques:
SUMOylation: SUMO-trap pulldown combined with YEH1 antibody detection
Acetylation: Immunoprecipitation with pan-acetyl antibodies followed by YEH1 detection
Glycosylation: Lectin affinity enrichment prior to YEH1 antibody analysis
Validation approaches:
Site-directed mutagenesis of putative modification sites
In vitro modification assays with purified enzymes
Correlation with known physiological stimuli that regulate YEH1 activity
Temporal analysis following cellular stress or metabolic shifts
When studying YEH1 PTMs, researchers should consider their potential regulatory impact on subcellular localization, protein stability, and enzymatic activity. Integrating multiple detection methods provides the most comprehensive characterization of YEH1's modification landscape .
Proximity labeling methods offer powerful approaches for mapping YEH1 protein interaction networks within their native cellular environment. Integration with YEH1 antibodies enhances these techniques through:
BioID/TurboID approach implementation:
Generate YEH1-biotin ligase fusion constructs (C-terminal fusion recommended)
Validate fusion protein localization and function
Optimize biotin concentration and labeling time
Perform streptavidin pulldown followed by mass spectrometry
APEX2 proximity labeling strategy:
Create YEH1-APEX2 fusions
Establish optimal H₂O₂ treatment conditions
Enrich biotinylated proteins using streptavidin
Identify proximity partners via proteomics
YEH1 antibody-enhanced validation:
Confirm identified interactions by co-immunoprecipitation with YEH1 antibodies
Perform reciprocal proximity labeling with key interaction partners
Use YEH1 antibodies for spatial co-localization studies
Implement comparative analysis between different growth conditions
Functional network analysis:
Categorize interaction partners by cellular function
Identify condition-specific interactions
Map interactions onto known lipid metabolism pathways
Test functional relevance through genetic interaction studies
To distinguish between stable and transient interactions, researchers should compare proximity labeling results with traditional co-immunoprecipitation data using YEH1 antibodies. This complementary approach helps establish a confidence hierarchy for the identified interactions .
Inconsistent performance of YEH1 antibodies across experimental replicates can significantly impact research reliability. To address this challenge:
Antibody quality assessment:
Test multiple antibody lots to identify lot-to-lot variability
Perform titration experiments to determine optimal working concentrations
Validate antibody specificity using YEH1-deficient controls
Consider monoclonal alternatives if polyclonal antibodies show inconsistency
Sample preparation standardization:
Implement strict harvest timing protocols (e.g., consistent OD₆₀₀ for yeast cultures)
Standardize lysis conditions (buffer composition, incubation time, temperature)
Adopt quantitative protein determination methods
Use fresh samples whenever possible or validate freezing protocols
Technical parameter optimization:
Standardize blocking conditions (agent, concentration, incubation time)
Optimize antibody incubation parameters (time, temperature, buffer composition)
Establish consistent washing protocols
Implement controlled image acquisition settings
Data analysis improvements:
Use internal controls for normalization
Implement quantitative analysis with appropriate statistical methods
Document all experimental conditions meticulously
Establish acceptance criteria for experimental validity
For critical experiments, researchers should consider parallel analysis using orthogonal detection methods or alternative YEH1 antibodies to increase confidence in their findings. Implementing a quality control program that tracks antibody performance over time can help identify degradation or other sources of variability .
YEH1's localization to different subcellular compartments can present challenges for antibody detection due to epitope masking effects. To overcome these obstacles:
Sample preparation modifications:
Optimize fixation protocols (duration, fixative type, temperature)
Test different permeabilization agents (Triton X-100, saponin, digitonin)
Evaluate antigen retrieval methods for fixed samples
Consider native vs. denaturing conditions based on epitope characteristics
Subcellular fraction-specific approaches:
For membrane-associated YEH1: Use mild detergents to preserve structure
For lipid droplet-associated YEH1: Implement specialized extraction protocols
For cytosolic pools: Develop differential extraction methods
For potential nuclear localization: Optimize nuclear isolation procedures
Epitope accessibility enhancement:
Test multiple antibodies targeting different epitopes
Consider enzymatic treatments to expose hidden epitopes
Evaluate different blocking agents to reduce background while preserving specificity
Implement longer incubation times at lower antibody concentrations
Complementary validation approaches:
Use epitope-tagged YEH1 constructs for parallel detection
Perform subcellular fractionation followed by immunoblotting
Implement super-resolution microscopy for detailed localization
Consider proximity ligation assays for in situ interaction detection
Researchers should document subcellular compartment-specific detection parameters, as optimal conditions may vary significantly between different cellular locations. Cross-validation with fluorescently tagged YEH1 can provide important confirmation of antibody-based localization studies .
Using YEH1 antibodies for quantitative analysis requires careful attention to multiple experimental parameters to ensure reliable and reproducible results:
Quantitative range determination:
Establish the linear detection range for the specific antibody
Develop standard curves using recombinant YEH1 or calibrated lysates
Determine the lower limit of detection and quantification
Verify that experimental samples fall within the established linear range
Technical standardization requirements:
Maintain consistent protein loading across samples
Implement robust loading controls appropriate for the experimental context
Use technical replicates to assess method precision
Apply identical image acquisition parameters across all samples
Data analysis methodology:
Select appropriate quantification software with background subtraction capabilities
Apply consistent region-of-interest selection criteria
Utilize appropriate statistical tests based on experimental design
Implement normalization strategies suitable for the specific application
Validation of quantitative findings:
Confirm changes using orthogonal methods (qPCR, mass spectrometry)
Perform spike-in recovery experiments to assess accuracy
Evaluate the impact of potential interfering substances
Assess reproducibility across independent biological replicates
For time-course experiments or comparative analyses across different growth conditions, researchers should implement rigorous internal controls and consider using multiplexed detection systems to minimize technical variability. When analyzing post-translational modifications, the ratio of modified to total YEH1 provides more reliable information than absolute quantities of modified protein .
Adapting single-cell analysis for YEH1 detection offers valuable insights into population heterogeneity in lipid metabolism. To implement these approaches effectively:
Flow cytometry adaptations:
Develop intracellular staining protocols compatible with yeast cell walls
Optimize fixation and permeabilization for YEH1 antibody accessibility
Implement multi-parameter analysis to correlate YEH1 levels with cellular states
Consider fluorescent protein fusions for live-cell analysis
Single-cell imaging techniques:
Establish high-content imaging workflows with automated cell segmentation
Develop quantitative image analysis pipelines for YEH1 intensity measurement
Implement microfluidic systems for time-lapse studies of individual cells
Combine with organelle-specific markers for colocalization analysis
Single-cell 'omics integration:
Correlate YEH1 protein levels with transcriptomic data from the same cells
Develop compatible protocols for simultaneous protein and lipid analysis
Implement index sorting to connect molecular profiles with phenotypic characteristics
Consider spatial transcriptomics approaches for tissue or colony organization studies
Technical considerations for reliable quantification:
Establish consistent autofluorescence correction methods
Implement appropriate controls for antibody specificity at the single-cell level
Develop computational approaches to distinguish technical from biological variability
Consider the impact of cell cycle position on YEH1 expression
Enhancing YEH1 antibody performance through advanced engineering approaches can significantly improve detection capabilities:
Recombinant antibody fragment development:
Generate single-chain variable fragments (scFvs) targeting YEH1-specific epitopes
Develop antigen-binding fragments (Fabs) with optimized affinity
Engineer bispecific antibodies targeting multiple YEH1 epitopes simultaneously
Create intrabodies optimized for intracellular expression and detection
Affinity maturation strategies:
Implement phage display for selective enrichment of high-affinity variants
Apply directed evolution approaches to enhance specificity
Utilize computational design to optimize binding interfaces
Perform deep mutational scanning to identify optimal antibody sequences
Novel conjugation and detection systems:
Develop site-specific conjugation methods for consistent labeling
Implement proximity-dependent amplification techniques
Create split-reporter systems for interaction-dependent detection
Engineer antibody-enzyme fusions for localized signal amplification
Yeast-specific adaptations:
Optimize antibody formats for penetration through yeast cell walls
Develop camelid single-domain antibodies (nanobodies) for enhanced accessibility
Create antibody derivatives resistant to yeast proteases
Engineer pH-resilient variants for detection across cellular compartments
Researchers interested in developing enhanced YEH1 detection reagents should consider collaborating with protein engineering specialists and implement rigorous validation protocols that compare new antibody formats with conventional approaches across a range of experimental conditions .
YEH1 antibodies can serve as valuable tools for comparative studies of lipid metabolism across fungal species, providing insights into evolutionary conservation and divergence:
Cross-species reactivity assessment:
Evaluate YEH1 antibody recognition across related yeast species
Perform epitope conservation analysis through sequence alignment
Test reactivity in pathogenic fungi with potential YEH1 homologs
Create epitope maps to identify invariant regions for broad-specificity antibodies
Comparative functional studies:
Deploy antibodies to track expression patterns under conserved stress conditions
Compare subcellular localization patterns across species
Evaluate co-immunoprecipitation patterns to identify conserved interaction networks
Assess post-translational modification conservation using specific antibodies
Methodological adaptations for diverse fungi:
Optimize extraction protocols for different cell wall compositions
Adjust immunoprecipitation conditions for species-specific cellular environments
Develop standardized quantification approaches for cross-species comparisons
Implement native protein analysis techniques for functional assessment
Evolutionary implications analysis:
Correlate antibody reactivity patterns with phylogenetic relationships
Identify species-specific modifications in expression regulation
Connect protein expression patterns with adaptive lipid metabolism strategies
Document lineage-specific functional divergence
This evolutionary approach can provide valuable insights into the core conserved functions of YEH1 versus species-specific adaptations, potentially revealing new targets for antifungal development or biotechnological applications. Researchers should combine antibody-based studies with genomic and biochemical approaches for comprehensive evolutionary analysis .